These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16984137)

  • 21. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.
    Sellman BR; Mourez M; Collier RJ
    Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
    Moayeri M; Wiggins JF; Leppla SH
    Infect Immun; 2007 Nov; 75(11):5175-84. PubMed ID: 17724066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M; Roehrl MH; Basar E; Wang JY
    Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat survival to anthrax lethal toxin is likely controlled by a single gene.
    Nye SH; Wittenburg AL; Evans DL; O'Connor JA; Roman RJ; Jacob HJ
    Pharmacogenomics J; 2008 Feb; 8(1):16-22. PubMed ID: 17440430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge.
    Banks DJ; Barnajian M; Maldonado-Arocho FJ; Sanchez AM; Bradley KA
    Cell Microbiol; 2005 Aug; 7(8):1173-85. PubMed ID: 16008584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of phage display and polyvalency to design inhibitors of protein-protein interactions.
    Mourez M; Collier RJ
    Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.
    Lim NK; Kim JH; Oh MS; Lee S; Kim SY; Kim KS; Kang HJ; Hong HJ; Inn KS
    Infect Immun; 2005 Oct; 73(10):6547-51. PubMed ID: 16177329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.
    Karginov VA; Nestorovich EM; Yohannes A; Robinson TM; Fahmi NE; Schmidtmann F; Hecht SM; Bezrukov SM
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3740-53. PubMed ID: 16982795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecule inhibitors of anthrax toxin-induced cytotoxicity targeted against protective antigen.
    Rubert Pérez C; López-Pérez D; Chmielewski J; Lipton M
    Chem Biol Drug Des; 2012 Mar; 79(3):260-9. PubMed ID: 22146079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-cyclodextrin derivatives that inhibit anthrax lethal toxin.
    Karginov VA; Yohannes A; Robinson TM; Fahmi NE; Alibek K; Hecht SM
    Bioorg Med Chem; 2006 Jan; 14(1):33-40. PubMed ID: 16169738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.
    Loving CL; Khurana T; Osorio M; Lee GM; Kelly VK; Stibitz S; Merkel TJ
    Infect Immun; 2009 Jan; 77(1):255-65. PubMed ID: 18955474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raftlike polyvalent inhibitors of the anthrax toxin: modulating inhibitory potency by formation of lipid microdomains.
    Rai PR; Saraph A; Ashton R; Poon V; Mogridge J; Kane RS
    Angew Chem Int Ed Engl; 2007; 46(13):2207-9. PubMed ID: 17310484
    [No Abstract]   [Full Text] [Related]  

  • 33. The Ins and Outs of Anthrax Toxin.
    Friebe S; van der Goot FG; Bürgi J
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26978402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized ATP protection against anthrax lethal toxin.
    Moayeri M; Wickliffe KE; Wiggins JF; Leppla SH
    Infect Immun; 2006 Jul; 74(7):3707-14. PubMed ID: 16790743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic assay-based screening identifies a potent inhibitor of anthrax lethal factor.
    Park HC; Sung SR; Lim SM; Lee JS; Kim SK; Yoon MY
    Microb Pathog; 2012 Aug; 53(2):109-12. PubMed ID: 22561400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable and potent polyvalent anthrax toxin inhibitors: raft-inspired domain formation in liposomes that contain PEGylated lipids.
    Rai P; Vance D; Poon V; Mogridge J; Kane RS
    Chemistry; 2008; 14(26):7748-51. PubMed ID: 18666271
    [No Abstract]   [Full Text] [Related]  

  • 37. Bacillus anthracis lethal toxin induces cell-type-specific cytotoxicity in human lung cell lines.
    Kim NY; Kang CI; Hur GH; Yang JM; Shin S
    J Appl Microbiol; 2014 May; 116(5):1334-43. PubMed ID: 24471528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of small molecule inhibitors of anthrax lethal factor.
    Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S
    Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into the functions of anthrax toxin.
    Banks DJ; Ward SC; Bradley KA
    Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.